Percent reduction in LDL cholesterol following high-intensity statin therapy: potential implications for guidelines and for the prescription of emerging lipid-lowering agents

医学 他汀类 药方 低密度脂蛋白胆固醇 胆固醇 还原(数学) 内科学 药理学 心脏病学 几何学 数学
作者
Paul M. Ridker,Samia Mora,Lynda M. Rose
出处
期刊:European Heart Journal [Oxford University Press]
卷期号:37 (17): 1373-1379 被引量:196
标识
DOI:10.1093/eurheartj/ehw046
摘要

Current statin guidelines in Europe and Canada advocate achieving a fixed LDL target or the attainment of a ≥50% reduction in low-density lipoprotein cholesterol (LDLC), while current US guidelines advocate the use of statin therapies that reduce LDLC by <50% (moderate intensity) or ≥50% (high intensity). Data are limited, however, linking the achievement of these % reduction thresholds to subsequent cardiovascular outcomes particularly for contemporary high-intensity regimens. In a randomized trial of 17 082 initially healthy men and women with median baseline LDLC of 108 mg/dL (interquartile range 94–119), we (i) used waterfall plots to assess the variability in LDLC response to rosuvastatin 20 mg daily and (ii) evaluated the impact of reaching ≥50% reductions in LDLC on risk of developing the first cardiovascular events. Among rosuvastatin allocated participants, 3640 individuals (46.3%) experienced an LDLC reduction ≥50%; 3365 individuals (42.8%) experienced an LDLC reduction >0 but <50%; and 851 individuals (10.8%) experienced no reduction or an increase in LDLC compared with baseline. These % LDLC reductions directly related to the risks of first cardiovascular events; at trial completion, incidence rates for the primary endpoint were 11.2, 9.2, 6.7, and 4.8 per 1000 person-years for those in the placebo, no LDLC reduction, LDLC reduction <50%, and LDLC reduction ≥50% groups, respectively. Compared with placebo, the multivariable adjusted hazard ratios for sequentially greater on-treatment per cent reductions in LDLC were 0.91 (95%CI 0.54–1.53), 0.61 (95%CI 0.44–0.83), and 0.43 (95%CI 0.30–0.60) (P < 0.00001). Similar relationships between % reduction and clinical outcomes were observed in analyses focusing on non-HDLC or apolipoprotein B. As documented for low- and moderate-intensity regimens, variability in % LDLC reduction following high-intensity statin therapy is wide yet the magnitude of this % reduction directly relates to efficacy. These data support guideline approaches that incorporate % reduction targets for statin therapy as well as absolute targets, and might provide a structure for the allocation of emerging adjunctive lipid-lowering therapies such as PCSK9 inhibitors should these agents prove broadly effective for cardiovascular event reduction.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
sh131完成签到,获得积分10
刚刚
呼噜呼噜小完成签到,获得积分10
刚刚
刚刚
东方耀发布了新的文献求助10
刚刚
量子星尘发布了新的文献求助10
2秒前
2秒前
十六发布了新的文献求助10
2秒前
L112233发布了新的文献求助10
3秒前
3秒前
3秒前
3秒前
科研人完成签到,获得积分10
4秒前
贪玩的谷芹完成签到 ,获得积分10
4秒前
5秒前
JamesPei应助内向万天采纳,获得10
5秒前
深情新之完成签到,获得积分20
5秒前
shanekhost完成签到 ,获得积分10
5秒前
活力的彩虹完成签到 ,获得积分10
5秒前
6秒前
打打应助JY采纳,获得10
6秒前
彭于彦祖应助之乡坞采纳,获得500
6秒前
CipherSage应助Wei采纳,获得10
7秒前
蜡笔小新完成签到,获得积分10
7秒前
东方耀完成签到,获得积分10
7秒前
Yummy完成签到,获得积分10
7秒前
7秒前
7秒前
7秒前
王慧完成签到,获得积分10
7秒前
8秒前
8秒前
smottom应助科研蚂蚁采纳,获得10
8秒前
8秒前
背后白梦完成签到,获得积分10
9秒前
羊羊羊完成签到,获得积分10
9秒前
黎芜发布了新的文献求助20
10秒前
10秒前
10秒前
周周完成签到,获得积分10
10秒前
默11完成签到 ,获得积分10
11秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3969383
求助须知:如何正确求助?哪些是违规求助? 3514211
关于积分的说明 11172730
捐赠科研通 3249476
什么是DOI,文献DOI怎么找? 1794909
邀请新用户注册赠送积分活动 875441
科研通“疑难数据库(出版商)”最低求助积分说明 804827